• Opinion
• [Reporter’s View] M&A storm blows through industry
• by Lee, Seok-Jun Aug 30, 2023 05:32am

• Opinion
• [Reporter's view] Hemophilia drug war of nerves
• by Kim, Jin-Gu Aug 24, 2023 05:46am

• Opinion
• [Reporter's view] There should be no recurrence of the Champ
• by Lee, Hye-Kyung Aug 17, 2023 05:29am

• Opinion
• [Reporter's view] Fight between AZ/Janssen
• by Jung, Sae-Im Aug 17, 2023 05:29am

• Opinion
• [Reporter's view] Prompt benefit registration
• by Eo, Yun-Ho Aug 10, 2023 05:33am

• Opinion
• [Reporter's view] When will Enhertu's benefit be available?
• by Jul 31, 2023 05:29am

• Opinion
• [Reporter's view] A groundbreaking policy is needed
• by Lee, Tak-Sun Jul 24, 2023 05:26am

• Opinion
• [Reporter's view]Time to think about price by indication
• by Eo, Yun-Ho Jul 19, 2023 05:20am

• Opinion
• [Reporter’s View]Kudos to Keytruda for filing 13 reimb apps
• by Eo, Yun-Ho Jul 5, 2023 05:45am

• Opinion
• [Reporter’s View] Gvn't policies hinder KOR pharma growth
• by Lee, Tak-Sun Jul 4, 2023 05:37am